Regeneron board member and executive sell $1 million in stock after Trump touts treatment
“These are pre-established at a time when the executive/director is not aware of any material, nonpublic information about Regeneron,” a spokesperson said.
“These are pre-established at a time when the executive/director is not aware of any material, nonpublic information about Regeneron,” a spokesperson said.
A review paper prompted a discussion among cardiologists Bob Harrington, Manesh Patel, and Michael Gibson on whether the ST-segment elevation myocardial infarction paradigm needs an…
Nature – Generative-AI models require massive amounts of data — scholarly publishers are licensing their content to train them.
A review paper prompted a discussion among cardiologists Bob Harrington, Manesh Patel, and Michael Gibson on whether the ST-segment elevation myocardial infarction paradigm needs an…
Nature – Generative-AI models require massive amounts of data — scholarly publishers are licensing their content to train them.
Trump’s top pick to lead Medicare, Dr. Mehmet Oz, has a glaring conflict of interest: that he was sponsored by the company that makes Ozempic.
Novartis failed to convince a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals’ proposed generic of Novartis’ blockbuster heart drug Entresto.
Misconceptions about the risks of hormone therapy have stuck around even in the wake of new research.
Misconceptions about the risks of hormone therapy have stuck around even in the wake of new research.
A new study shows a steep drop in cervical cancer deaths among the first cohort of women who were eligible for the HPV vaccine.
A new study shows a steep drop in cervical cancer deaths among the first cohort of women who were eligible for the HPV vaccine.